Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist

Fertility and Sterility

Volumn 83, Issue 4, 2005, Pages 902-907

  Cunha Filho, João Sabino ^a   Lemos, Nadiane ^a   Stein, Nina ^a   Laranjeira, Andréia ^a   Passos, Eduardo Pandolfi ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

GnRH antagonist; Inhibin A; Minimal stimulation; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST; INHIBIN A; RECOMBINANT FOLLITROPIN; VASCULOTROPIN;

ADULT; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 17044364279     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.11.027     Document Type: Article

References (27)

1. S. Christin-Maitre, F. Olivennes, S. Dubourdieu, N. Chabbert-Buffet, B. Charbonnel, R. Frydman Effect of GnRH antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation Clinic Endocrinol 52 2000 721 726
2. The European Orgalutran Study Group Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial Hum Reprod 15 2000 1490 1498
3. The European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 2001 644 651
4. The Ganirelix Dose-Finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Hum Reprod 13 1998 3023 3031
5. C. Albano, R.E. Felberbaum, J. Smitz, H. Riethmüller-Winzen, J. Engel, K. Diedrich European Cetrorelix Study Group Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin Hum Reprod 15 2000 526 531
6. F. Olivennes, J. Belaisch-Allart, J.C. Emperaire, H. Dechaud, S. Alvarez, L. Moreau A prospective randomized controlled study in IVF-ET with a single dose of an LH-RH antagonist (cetrorelix) or a depot formula of a LH-RH agonist (triptorelin) Fertil Steril 73 2000 314 320
7. F. Olivennes, J.S. Cunha-Filho, R. Fanchin, P. Bouchard, R. Frydman The use of GnRH antagonists in ovarian stimulation Human Reprod Update 8 2002 279 290
8. C. Rongières-Bertrand, F. Olivennes, C. Righini, R. Fanchin, J. Taïeb, S. Hamamah Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotropin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation Hum Reprod 14 1999 683 688
9. E. Geva, R.B. Jaffe Role of vascular endothelial growth factor in ovarian physiology and pathology Fertil Steril 74 3 2000 429 438
10. R. Quintana, L. Kopcow, G. Marconi, C. Sueldo, G. Speranza, R.I. Baranao Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis Hum Reprod 16 9 2001 1814 1818
11. J.L. Benifla, A.F. Bringuier, C. Sifer, R. Porcher, P. Madelenat, G. Feldmann Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF Hum Reprod 16 7 2001 1376 1381
12. G. Barroso, M. Barrionuevo, P. Rao, L. Graham, D. Danforth, S. Huey Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients Fertil Steril 72 6 1999 1024 1026
13. C. Battaglia, A.D. Genazzani, G. Regnani, M.R. Primavera, F. Petraglia, A. Volpe Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders Fertil Steril 74 4 2000 809 812
14. N.A. Klein, D.E. Battaglia, T.K. Woodruff, V. Padmanabhan, L.C. Giudice, W.J. Bremner Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age J Clin Endocrinol Metab 85 12 2000 4520 4525
15. C.I. Friedman, D.B. Seifer, E.A. Kennard, L. Arbogast, B. Alak, D.R. Danforth Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential Fertil Steril 70 5 1998 836 839
16. C.I. Friedman, D.R. Danforth, C. Herbosa-Encarnacion, L. Arbogast, B.M. Alak, D.B. Seifer Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction Fertil Steril 68 4 1997 607 612
17. J. Van Blerkom, M. Antczak, R. Schrader The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics Hum Reprod 12 5 1997 1047 1055
18. C.K. Welt, Z.A. Smith, D.K. Pauler, J.E. Hall Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development J Clin Endocrinol Metab 86 6 2001 2531 2537
19. C.P. Lau, W.L. Ledger, N.P. Groome, D.H. Barlow, S. Muttukrishna Dimeric inhibins and activin A in human follicular fluid and oocyte-cumulus culture medium Hum Reprod 14 10 1999 2525 2530
20. D.A. Magoffin, A.J. Jakimiuk Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women Hum Reprod 12 8 1997 1714 1719
21. E.R. Hernandez Embryo implantation and GnRH antagonists Embryo implantation: the rubicon for GnRH antagonists Hum Reprod 15 2000 1211 1216
22. N. Nikolettos, S. Al-Hasani, R. Felberbaum, L.C. Demirel, H. Riethmuller-Winzen, T. Reissmann Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, Cetrorelix, and GnRH agonist Eur J Obstet Gynecol Reprod Biol 93 2000 91 95
23. O. Tokuyama, Y. Nakamura, A. Muso, Y. Fujino, O. Ishiko, S. Ogita Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle J Assist Reprod Genet 19 1 2002 19 23
24. A.L. Schneyer, T. Fujiwara, J. Fox, C.K. Welt, J. Adams, G.M. Messerlian Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations J Clin Endocrinol Metab 85 9 2000 3319 3330
25. J.E. Hall, C.K. Welt, D.W. Cramer Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome Hum Reprod 14 2 1999 409 415
26. H. Al-Inany, M. Aboulghar GnRH antagonist in assisted reproduction: a Cochrane review Hum Reprod 17 4 2002 874 885
27. E. Ricciarelli, M. Sanchez, M. Martinez, L. Andres, J. Cuadros, E.R. Hernandez Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles Fertil Steril 79 6 2003 1461 1463